Chat with us, powered by LiveChat
Continuing Education for Pharmacists and Pharmacy Technicians
Pharmacy CE
ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians

A Paradigm Shift in Nonalcoholic Fatty Liver Disease Management – 1 CE – Live Webinar on September 27, 2022 8PM ET

Activity Overview

Nonalcoholic liver disease (NAFLD) is the most common cause of liver disease in the United States and is associated with significant morbidity and mortality once NALFD progresses to nonalcoholic steatohepatitis (NASH). NASH is predicted to become the main indication for liver transplant in the United States as obesity rates continue to rise. Currently, management of NAFLD is limited to lifestyle modifications with pharmacotherapy gaps. Once NAFLD has progressed to NASH, the use of offlabel medications including thiazolidines and vitamin E can be considered. However, in recent years, GLP1 agonists and SGLT2 antagonists have demonstrated efficacy in reversing hepatosteatosis and fibrosis in several studies in NAFLD and early NASH. Additionally, several novel agents are in phase III clinical studies for the treatment of NASH. The scope of treatment of NAFLD and NASH is likely to change dramatically in the next decade as the burden of disease increases.

This CE will review current guidelines comparing recommendations to emerging treatment options, evaluate current literature on the use of GLP1 agonists and SGLT2 inhibitors in the treatment of NAFLD, and explore strategies for implementation in current practice. Lastly, the role of emerging treatments with novel mechanisms in Phase III clinical studies will be discussed.

Pharmacist Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Recognize the associated burden of disease due to non-alcoholic liver disease (NAFLD) in adult patients
  2. Discuss the pathophysiology and clinical presentation of NAFLD
  3. Review current national guideline recommendations for the treatment of patients with NAFLD
  4. Evaluate recent literature on emerging treatment options and the real-world application for the management of NAFLD patients 

          BUY NOW

Accreditation Statement

ACPEAchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-882588.

Faculty Information

Erenie Guirguis, PharmD, BCPS attended Palm Beach Atlantic University for her Doctor of Pharmacy degree then pursued a pharmacy practice residency at the Miami Veterans Affairs Hospital in Miami, Florida. After completing residency, she pursued board certification in pharmacotherapy and is currently an associate professor of pharmacy practice at Palm Beach Atlantic University with expertise in internal medicine. Her teaching responsibilities include coordinating and teaching a special populations pharmacotherapy course as well as teaching liver diseases in the Gastrointestinal and Renal Pharmacotherapy course. As an internal medicine faculty member, she has been practicing in internal medicine with an interdisciplinary team at several teaching hospitals for over 10 years. Additionally, she is involved in research and has published several review articles on off-label use of medications as well as other internal medicine pharmacotherapy topics. She has also been an invited speaker at local and national meetings.

Financial Support Disclosure

This activity was developed by AchieveCE free of any commercial support. Erenie Guirguis, PharmD, BCPS  has no actual or potential conflicts of interest to disclose.

Content Complexity

  Level 2. Basic Application of Skills and Concepts

Delivery Type

Live Webinar

}

Credits

1.0 Contact Hour

Category

Disease State Management/Drug Therapy

Target Audience

Pharmacist

Activity Type

Knowledge-based

Universal Activity Number

Pharmacist: 
0657-0000-21-117-L01-P

Airing Schedule

September 27, 2022 (Tue)
8 PM Eastern Time

Activity Release Date

September 30, 2021

Activity Expiration Date

September 30, 2024

Cost

$25.00

Handout Download Link(s)

Already a Member?

Requirements for Credit

Participants must correctly enter the 4-digit evaluation access code provided into the test at the conclusion of the webinar and complete an activity evaluation. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile and if the course is completed on the same day of the webinar. If you fail to complete the attendance confirmation on the same day, please contact AchieveCE’s customer support to ensure your credits are reported.

CE Broker Reporting

If you are licensed under a board supported by CE Broker, feel free to log into your CE Broker account to view your reported courses or to contact their support staff.

Hardware Requirements

Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+

Software Requirements

Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader

Network Requirements

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

Get Unlimited CE!

Get unlimited CE for one low annual fee.
Save time and money by becoming a member!

Need more Pharmacy CEs?

Check out other live webinars and home study activities to study at your own time!